New hope for bowel cancer patients
2 min read
Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles directly to tumours instead of being taken orally. T...
news, national

hat's the conclusion of an Indian and Australian study that used nanoparticles to target bowel cancer, the third-most common cancer in the world and the second-deadliest. In animal experiments researchers found that nanoparticles containing the chemotherapy drug Capecitabine (CAP) attach themselves directly to the diseased cells, bypassing healthy cells and reducing toxic side effects as well as the size and number of tumours. The Australian researcher involved in the project, UniSA Professor Sanjay Garg, says CAP is the first-line chemotherapy drug for bowel cancer. "A high dose is necessary to maintain effective concentration, resulting in some…
Read full article